These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 2653418

  • 1. Does vitreous fluorophotometry reflect severity of early diabetic retinopathy?
    Plehwe WE, Sleightholm MA, Kohner EM.
    Br J Ophthalmol; 1989 Apr; 73(4):255-60. PubMed ID: 2653418
    [Abstract] [Full Text] [Related]

  • 2. Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy.
    Lobo CL, Bernardes RC, Figueira JP, de Abreu JR, Cunha-Vaz JG.
    Arch Ophthalmol; 2004 Feb; 122(2):211-7. PubMed ID: 14769598
    [Abstract] [Full Text] [Related]

  • 3. Effect of morphological abnormalities on blood retinal barrier permeability in diabetic retinopathy.
    van Gerven JM, Boot JP, Lemkes HH, van Best JA.
    Doc Ophthalmol; 1992 Feb; 80(2):183-8. PubMed ID: 1425133
    [Abstract] [Full Text] [Related]

  • 4. Posterior vitreous fluorophotometry in diabetic patients with minimal or no retinopathy.
    Roy MS, Podgor MJ, Bungay P, Grunberger G, Carl J, Ellis D.
    Retina; 1987 Feb; 7(3):170-6. PubMed ID: 3423432
    [Abstract] [Full Text] [Related]

  • 5. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
    Gardner TW, Eller AW, Friberg TR, D'Antonio JA, Hollis TM.
    Retina; 1995 Feb; 15(2):134-40. PubMed ID: 7624601
    [Abstract] [Full Text] [Related]

  • 6. [Structural and functional disorders of transcapillary metabolism if retina in patients with diabetic retinopathy].
    Sorokin EL, Smoliakova GP.
    Vestn Oftalmol; 1997 Feb; 113(2):16-9. PubMed ID: 9229896
    [Abstract] [Full Text] [Related]

  • 7. A follow-up study by vitreous fluorophotometry of early retinal involvement in diabetes.
    Cunha-Vaz JG, Fonseca JR, Abreu JF, Ruas MA.
    Am J Ophthalmol; 1978 Oct; 86(4):467-73. PubMed ID: 707592
    [Abstract] [Full Text] [Related]

  • 8. Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter.
    Sander B, Thornit DN, Colmorn L, Strøm C, Girach A, Hubbard LD, Lund-Andersen H, Larsen M.
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):3983-7. PubMed ID: 17724176
    [Abstract] [Full Text] [Related]

  • 9. [Early diagnosis of diabetic retinopathy in patients with diabetes type I, using vitreous fluorophotometry].
    Janiec S, Sośnierz-Jupowiecka A, Rzendkowski M.
    Klin Oczna; 1994 Sep; 96(8-9):265-7. PubMed ID: 7897991
    [Abstract] [Full Text] [Related]

  • 10. Vitreous fluorophotometry in patients with no or minimal diabetic retinopathy.
    Chahal P, Fallon TJ, Jennings SJ, Chowienczyk PJ, Kohner EM.
    Diabetes Care; 1986 Sep; 9(2):134-9. PubMed ID: 3698779
    [Abstract] [Full Text] [Related]

  • 11. Analysis of the blood-retinal barrier: its relation to clinical and metabolic factors and progression to retinopathy in juvenile diabetics. A 4-year follow-up study.
    Castillo A, Benitez del Castillo JM, Diaz D, Sayagues O, Ruibal JL, Garcia-Sanchez J.
    Graefes Arch Clin Exp Ophthalmol; 1996 Apr; 234(4):246-50. PubMed ID: 8964530
    [Abstract] [Full Text] [Related]

  • 12. Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.
    Ribeiro ML, Seres AI, Carneiro AM, Stur M, Zourdani A, Caillon P, Cunha-Vaz JG, DX-Retinopathy Study Group.
    Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1591-600. PubMed ID: 16763797
    [Abstract] [Full Text] [Related]

  • 13. Can vitreous fluorophotometry predict the necessity for photocoagulation? A 5-year follow-up study.
    Knudsen LL, Nielsen-Kudsk F.
    Acta Ophthalmol Scand; 2000 Aug; 78(4):390-5. PubMed ID: 10990038
    [Abstract] [Full Text] [Related]

  • 14. Long-term kinetic vitreous fluorophotometry in normal and diabetic subjects.
    Knudsen LL, Olsen T, Nielsen-Kudsk F.
    Acta Ophthalmol (Copenh); 1992 Oct; 70(5):570-7. PubMed ID: 1471478
    [Abstract] [Full Text] [Related]

  • 15. Localised blood-retinal barrier leakage and retinal light sensitivity in diabetic retinopathy.
    Bek T, Lund-Andersen H.
    Br J Ophthalmol; 1990 Jul; 74(7):388-92. PubMed ID: 2378853
    [Abstract] [Full Text] [Related]

  • 16. Studies on the pathophysiology of diabetic retinopathy. The blood-retinal barrier in diabetes.
    Cunha-Vaz JG.
    Diabetes; 1983 May; 32 Suppl 2():20-7. PubMed ID: 6400666
    [Abstract] [Full Text] [Related]

  • 17. The blood-ocular barrier in type I diabetes without diabetic retinopathy: permeability measurements using fluorophotometry.
    Schalnus R, Ohrloff C.
    Ophthalmic Res; 1995 May; 27 Suppl 1():116-23. PubMed ID: 8577448
    [Abstract] [Full Text] [Related]

  • 18. Progression of retinopathy and alteration of the blood-retinal barrier in patients with type 2 diabetes: a 7-year prospective follow-up study.
    Cunha-Vaz J, Lobo C, Sousa JC, Oliveiros B, Leite E, de Abreu JR.
    Graefes Arch Clin Exp Ophthalmol; 1998 Apr; 236(4):264-8. PubMed ID: 9561358
    [Abstract] [Full Text] [Related]

  • 19. Nonmydriatic ultrawide field retinal imaging compared with dilated standard 7-field 35-mm photography and retinal specialist examination for evaluation of diabetic retinopathy.
    Silva PS, Cavallerano JD, Sun JK, Noble J, Aiello LM, Aiello LP.
    Am J Ophthalmol; 2012 Sep; 154(3):549-559.e2. PubMed ID: 22626617
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of diabetic retinopathy by fluorophotometry. European concerted action on ocular fluorometry.
    Van Schaik HJ, Benitez del Castillo JM, Caubergh MJ, Gobert A, Leite E, Moldow B, Rosas V, Van Best JA.
    Int Ophthalmol; 2012 Sep; 22(2):97-104. PubMed ID: 10472769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.